| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 2.36e-04 | 560 | 45 | 7 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 2.52e-04 | 566 | 45 | 7 | GO:0001216 | |
| GeneOntologyMolecularFunction | co-SMAD binding | 3.23e-04 | 12 | 45 | 2 | GO:0070410 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 8.22e-04 | 187 | 45 | 4 | GO:0016922 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 9.28e-04 | 85 | 45 | 3 | GO:0038024 | |
| GeneOntologyMolecularFunction | death receptor binding | 1.44e-03 | 25 | 45 | 2 | GO:0005123 | |
| GeneOntologyMolecularFunction | R-SMAD binding | 1.56e-03 | 26 | 45 | 2 | GO:0070412 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 2.38e-03 | 417 | 45 | 5 | GO:0061629 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 2.50e-03 | 120 | 45 | 3 | GO:0008013 | |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 2.66e-03 | 34 | 45 | 2 | GO:0046966 | |
| GeneOntologyBiologicalProcess | vesicle cargo loading | 1.32e-06 | 36 | 47 | 4 | GO:0035459 | |
| GeneOntologyBiologicalProcess | embryo development | DLG3 TBX3 HOXC4 KMT2D TCF7L2 LATS2 FOXH1 TRIP6 TCF7L1 MED12 SMAD6 FOSL1 | 6.62e-05 | 1437 | 47 | 12 | GO:0009790 |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 2.57e-06 | 42 | 48 | 4 | GO:0070971 | |
| GeneOntologyCellularComponent | tight junction | 2.90e-04 | 139 | 48 | 4 | GO:0070160 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 3.90e-04 | 272 | 48 | 5 | GO:0090575 | |
| GeneOntologyCellularComponent | beta-catenin-TCF complex | 3.96e-04 | 13 | 48 | 2 | GO:1990907 | |
| GeneOntologyCellularComponent | apical junction complex | 4.72e-04 | 158 | 48 | 4 | GO:0043296 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | SRRM1 KMT2D TCF7L2 FOXH1 PRDM4 TCF7L1 MED12 GPATCH1 SMAD6 FOSL1 | 9.73e-04 | 1377 | 48 | 10 | GO:0140513 |
| MousePheno | decreased circulating VLDL triglyceride level | 1.61e-05 | 19 | 37 | 3 | MP:0003976 | |
| Domain | Tyr_Pase_non-rcpt_typ-14/21 | 5.18e-06 | 2 | 43 | 2 | IPR014392 | |
| Domain | HMG_box_dom | 1.49e-05 | 65 | 43 | 4 | IPR009071 | |
| Domain | CTNNB1-bd_N | 3.10e-05 | 4 | 43 | 2 | IPR013558 | |
| Domain | CTNNB1_binding | 3.10e-05 | 4 | 43 | 2 | PF08347 | |
| Domain | TCF/LEF | 3.10e-05 | 4 | 43 | 2 | IPR024940 | |
| Domain | HMG_box | 2.46e-04 | 53 | 43 | 3 | PF00505 | |
| Domain | - | 2.57e-04 | 391 | 43 | 6 | 2.30.29.30 | |
| Domain | HMG | 2.60e-04 | 54 | 43 | 3 | SM00398 | |
| Domain | - | 2.74e-04 | 55 | 43 | 3 | 1.10.30.10 | |
| Domain | PH_dom-like | 4.06e-04 | 426 | 43 | 6 | IPR011993 | |
| Domain | FERM_CS | 1.38e-03 | 24 | 43 | 2 | IPR019747 | |
| Domain | FERM_C | 1.62e-03 | 26 | 43 | 2 | PF09380 | |
| Domain | FERM_C | 1.75e-03 | 27 | 43 | 2 | SM01196 | |
| Domain | FERM_PH-like_C | 1.75e-03 | 27 | 43 | 2 | IPR018980 | |
| Domain | Fibrinogen_C | 1.75e-03 | 27 | 43 | 2 | PF00147 | |
| Domain | Catenin_binding_dom | 2.02e-03 | 29 | 43 | 2 | IPR027397 | |
| Domain | FBG | 2.02e-03 | 29 | 43 | 2 | SM00186 | |
| Domain | - | 2.02e-03 | 29 | 43 | 2 | 4.10.900.10 | |
| Domain | - | 2.16e-03 | 30 | 43 | 2 | 3.90.215.10 | |
| Domain | Fibrinogen_a/b/g_C_1 | 2.16e-03 | 30 | 43 | 2 | IPR014716 | |
| Domain | FIBRINOGEN_C_1 | 2.46e-03 | 32 | 43 | 2 | PS00514 | |
| Domain | Fibrinogen_a/b/g_C_dom | 2.46e-03 | 32 | 43 | 2 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 2.46e-03 | 32 | 43 | 2 | PS51406 | |
| Domain | FERM_N | 2.61e-03 | 33 | 43 | 2 | PF09379 | |
| Domain | FERM_N | 2.61e-03 | 33 | 43 | 2 | IPR018979 | |
| Domain | PTPc | 3.10e-03 | 36 | 43 | 2 | SM00194 | |
| Domain | TYR_PHOSPHATASE_PTP | 3.63e-03 | 39 | 43 | 2 | PS50055 | |
| Domain | PH | 3.76e-03 | 278 | 43 | 4 | SM00233 | |
| Domain | PH_DOMAIN | 3.81e-03 | 279 | 43 | 4 | PS50003 | |
| Domain | PH_domain | 3.85e-03 | 280 | 43 | 4 | IPR001849 | |
| Domain | PTPase_domain | 4.01e-03 | 41 | 43 | 2 | IPR000242 | |
| Domain | Y_phosphatase | 4.01e-03 | 41 | 43 | 2 | PF00102 | |
| Domain | PDZ | 4.17e-03 | 141 | 43 | 3 | PF00595 | |
| Domain | PDZ | 4.77e-03 | 148 | 43 | 3 | SM00228 | |
| Domain | - | 4.95e-03 | 150 | 43 | 3 | 2.30.42.10 | |
| Domain | SET | 5.03e-03 | 46 | 43 | 2 | SM00317 | |
| Domain | FERM_M | 5.03e-03 | 46 | 43 | 2 | PF00373 | |
| Domain | PDZ | 5.05e-03 | 151 | 43 | 3 | PS50106 | |
| Domain | PDZ | 5.14e-03 | 152 | 43 | 3 | IPR001478 | |
| Domain | - | 5.69e-03 | 49 | 43 | 2 | 1.20.80.10 | |
| Domain | FERM_central | 5.69e-03 | 49 | 43 | 2 | IPR019748 | |
| Domain | FERM_domain | 5.69e-03 | 49 | 43 | 2 | IPR000299 | |
| Domain | SET_dom | 5.91e-03 | 50 | 43 | 2 | IPR001214 | |
| Domain | FERM_1 | 5.91e-03 | 50 | 43 | 2 | PS00660 | |
| Domain | FERM_2 | 5.91e-03 | 50 | 43 | 2 | PS00661 | |
| Domain | SET | 5.91e-03 | 50 | 43 | 2 | PS50280 | |
| Domain | FERM_3 | 5.91e-03 | 50 | 43 | 2 | PS50057 | |
| Domain | Band_41_domain | 5.91e-03 | 50 | 43 | 2 | IPR019749 | |
| Domain | B41 | 5.91e-03 | 50 | 43 | 2 | SM00295 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 5.91e-03 | 50 | 43 | 2 | IPR014352 | |
| Domain | HMG_BOX_2 | 6.87e-03 | 54 | 43 | 2 | PS50118 | |
| Pathway | PID_AP1_PATHWAY | 2.60e-05 | 70 | 35 | 4 | M167 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 3.51e-05 | 26 | 35 | 3 | MM14793 | |
| Pathway | REACTOME_RUNX3_REGULATES_WNT_SIGNALING | 8.93e-05 | 6 | 35 | 2 | MM15542 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_AVRA_TO_BETA_CATENIN_SIGNALING_PATHWAY | 8.93e-05 | 6 | 35 | 2 | M47736 | |
| Pathway | REACTOME_CARGO_CONCENTRATION_IN_THE_ER | 9.46e-05 | 36 | 35 | 3 | MM15300 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 1.21e-04 | 39 | 35 | 3 | MM17226 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_LANA_TO_WNT_SIGNALING_PATHWAY | 1.25e-04 | 7 | 35 | 2 | M47465 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 1.51e-04 | 42 | 35 | 3 | M27272 | |
| Pathway | WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT | 1.53e-04 | 110 | 35 | 4 | M39492 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_CELL_CYCLE_AND_PROLIFERATION | 1.66e-04 | 8 | 35 | 2 | MM17229 | |
| Pathway | REACTOME_BINDING_OF_TCF_LEF_CTNNB1_TO_TARGET_GENE_PROMOTERS | 1.66e-04 | 8 | 35 | 2 | M27359 | |
| Pathway | KEGG_MEDICUS_VARIANT_CDH1_REDUCED_EXPRESSION_TO_BETA_CATENIN_SIGNALING_PATHWAY | 1.66e-04 | 8 | 35 | 2 | M47413 | |
| Pathway | REACTOME_RUNX3_REGULATES_WNT_SIGNALING | 1.66e-04 | 8 | 35 | 2 | M27821 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_AXIN_TO_WNT_SIGNALING_PATHWAY | 2.66e-04 | 10 | 35 | 2 | M47486 | |
| Pathway | REACTOME_REPRESSION_OF_WNT_TARGET_GENES | 2.66e-04 | 10 | 35 | 2 | MM15156 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_APC_TO_WNT_SIGNALING_PATHWAY | 3.89e-04 | 12 | 35 | 2 | M47410 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 4.14e-04 | 59 | 35 | 3 | M39886 | |
| Pathway | REACTOME_REPRESSION_OF_WNT_TARGET_GENES | 5.35e-04 | 14 | 35 | 2 | M27402 | |
| Pathway | WP_MESODERMAL_COMMITMENT_PATHWAY | 5.38e-04 | 153 | 35 | 4 | M39546 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 7.03e-04 | 16 | 35 | 2 | MM17241 | |
| Pathway | WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS | 7.96e-04 | 17 | 35 | 2 | M39443 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_CELL_CYCLE_AND_PROLIFERATION | 7.96e-04 | 17 | 35 | 2 | M48240 | |
| Pathway | PID_BETA_CATENIN_NUC_PATHWAY | 1.01e-03 | 80 | 35 | 3 | M223 | |
| Pathway | WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA | 1.38e-03 | 89 | 35 | 3 | M39563 | |
| Pathway | KEGG_PROSTATE_CANCER | 1.38e-03 | 89 | 35 | 3 | M13191 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 1.47e-03 | 91 | 35 | 3 | M27101 | |
| Pathway | WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER | 1.81e-03 | 98 | 35 | 3 | M39731 | |
| Pathway | WP_HIPPO_SIGNALING_REGULATION | 1.81e-03 | 98 | 35 | 3 | M39830 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | DLG3 TBX3 HOXC4 KMT2D TCF7L2 FOXH1 TCF7L1 MED12 ITSN1 CNTNAP1 | 1.93e-03 | 1432 | 35 | 10 | M509 |
| Pathway | WP_WNT_SIGNALING_AND_PLURIPOTENCY | 1.98e-03 | 101 | 35 | 3 | M39387 | |
| Pathway | KEGG_THYROID_CANCER | 2.33e-03 | 29 | 35 | 2 | M523 | |
| Pathway | WP_WNT_SIGNALING_WP428 | 2.72e-03 | 113 | 35 | 3 | M39669 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 2.83e-03 | 32 | 35 | 2 | MM14975 | |
| Pubmed | Mea6 controls VLDL transport through the coordinated regulation of COPII assembly. | 9.86e-09 | 4 | 48 | 3 | 27311593 | |
| Pubmed | 9.86e-09 | 4 | 48 | 3 | 31244610 | ||
| Pubmed | 9.86e-09 | 4 | 48 | 3 | 21807889 | ||
| Pubmed | Deletion of Mea6 in Cerebellar Granule Cells Impairs Synaptic Development and Motor Performance. | 9.86e-09 | 4 | 48 | 3 | 33718348 | |
| Pubmed | 9.86e-09 | 4 | 48 | 3 | 12586826 | ||
| Pubmed | cTAGE: a cutaneous T cell lymphoma associated antigen family with tumor-specific splicing. | 2.46e-08 | 5 | 48 | 3 | 12839582 | |
| Pubmed | 2.46e-08 | 5 | 48 | 3 | 18630941 | ||
| Pubmed | 2.46e-08 | 5 | 48 | 3 | 19131326 | ||
| Pubmed | Characterization and expression pattern of the novel MIA homolog TANGO. | 2.46e-08 | 5 | 48 | 3 | 15183315 | |
| Pubmed | Mea6/cTAGE5 cooperates with TRAPPC12 to regulate PTN secretion and white matter development. | 2.46e-08 | 5 | 48 | 3 | 38439956 | |
| Pubmed | A tissue-specific atlas of mouse protein phosphorylation and expression. | 2.46e-08 | 5 | 48 | 3 | 21183079 | |
| Pubmed | cTAGE5 deletion in pancreatic β cells impairs proinsulin trafficking and insulin biogenesis in mice. | 8.60e-08 | 7 | 48 | 3 | 29133483 | |
| Pubmed | Misexpression of MIA disrupts lung morphogenesis and causes neonatal death. | 2.06e-07 | 9 | 48 | 3 | 18342301 | |
| Pubmed | Ultrastructural cartilage abnormalities in MIA/CD-RAP-deficient mice. | 6.99e-07 | 13 | 48 | 3 | 11839810 | |
| Pubmed | Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. | 1.11e-06 | 15 | 48 | 3 | 15866165 | |
| Pubmed | cTAGE5/MEA6 plays a critical role in neuronal cellular components trafficking and brain development. | 1.11e-06 | 15 | 48 | 3 | 30224460 | |
| Pubmed | Restricted high level expression of Tcf-4 protein in intestinal and mammary gland epithelium. | 1.87e-06 | 2 | 48 | 2 | 9916915 | |
| Pubmed | A gene family of HMG-box transcription factors with homology to TCF-1. | 1.87e-06 | 2 | 48 | 2 | 1741298 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 23339869 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 26298725 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 33684622 | ||
| Pubmed | 3.73e-06 | 22 | 48 | 3 | 17919533 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 17607356 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 25659031 | ||
| Pubmed | In vivo transcriptional governance of hair follicle stem cells by canonical Wnt regulators. | 5.59e-06 | 3 | 48 | 2 | 24463605 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 25988230 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 20532534 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 34525377 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 32403323 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 8.69e-06 | 351 | 48 | 6 | 38297188 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 9.97e-06 | 774 | 48 | 8 | 15302935 | |
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 33587034 | ||
| Pubmed | Mapping canonical Wnt signaling in the developing and adult retina. | 1.12e-05 | 4 | 48 | 2 | 17065530 | |
| Pubmed | 1.71e-05 | 36 | 48 | 3 | 33230114 | ||
| Pubmed | Phosphorylation of TCF proteins by homeodomain-interacting protein kinase 2. | 1.86e-05 | 5 | 48 | 2 | 21285352 | |
| Pubmed | 1.90e-05 | 1116 | 48 | 9 | 31753913 | ||
| Pubmed | 2.35e-05 | 40 | 48 | 3 | 30865227 | ||
| Pubmed | The phagosomal proteome in interferon-gamma-activated macrophages. | 2.35e-05 | 40 | 48 | 3 | 19144319 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 2.73e-05 | 430 | 48 | 6 | 35044719 | |
| Pubmed | 2.79e-05 | 6 | 48 | 2 | 9488439 | ||
| Pubmed | 2.79e-05 | 6 | 48 | 2 | 23152144 | ||
| Pubmed | 2.79e-05 | 6 | 48 | 2 | 11731231 | ||
| Pubmed | Dazap2 modulates transcription driven by the Wnt effector TCF-4. | 2.79e-05 | 6 | 48 | 2 | 19304756 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | 3.13e-05 | 908 | 48 | 8 | 19274049 | |
| Pubmed | β-catenin and γ-catenin are dispensable for T lymphocytes and AML leukemic stem cells. | 3.90e-05 | 7 | 48 | 2 | 32820720 | |
| Pubmed | RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis. | 3.90e-05 | 7 | 48 | 2 | 18772112 | |
| Pubmed | 3.90e-05 | 7 | 48 | 2 | 19303461 | ||
| Pubmed | The G protein-coupled receptor CL1 interacts directly with proteins of the Shank family. | 5.19e-05 | 8 | 48 | 2 | 10958799 | |
| Pubmed | 5.19e-05 | 8 | 48 | 2 | 21177349 | ||
| Pubmed | TWIST1 Homodimers and Heterodimers Orchestrate Lineage-Specific Differentiation. | 5.19e-05 | 8 | 48 | 2 | 32179550 | |
| Pubmed | Tbx2 and Tbx3 regulate the dynamics of cell proliferation during heart remodeling. | 5.19e-05 | 8 | 48 | 2 | 17460765 | |
| Pubmed | 6.50e-05 | 56 | 48 | 3 | 22745667 | ||
| Pubmed | Wnt3a regulates Lef-1 expression during airway submucosal gland morphogenesis. | 6.67e-05 | 9 | 48 | 2 | 17335794 | |
| Pubmed | 8.33e-05 | 10 | 48 | 2 | 27491074 | ||
| Pubmed | 8.33e-05 | 10 | 48 | 2 | 30429287 | ||
| Pubmed | 8.33e-05 | 10 | 48 | 2 | 22990020 | ||
| Pubmed | A critical role for the Wnt effector Tcf4 in adult intestinal homeostatic self-renewal. | 8.33e-05 | 10 | 48 | 2 | 22393260 | |
| Pubmed | Expression of Tcf/Lef and sFrp and localization of beta-catenin in the developing mouse lung. | 1.02e-04 | 11 | 48 | 2 | 11731265 | |
| Pubmed | Tcf7L2 is essential for neurogenesis in the developing mouse neocortex. | 1.02e-04 | 11 | 48 | 2 | 29751817 | |
| Pubmed | Hippo Signaling Suppresses Cell Ploidy and Tumorigenesis through Skp2. | 1.02e-04 | 11 | 48 | 2 | 28486106 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 1.07e-04 | 341 | 48 | 5 | 32971831 | |
| Pubmed | 1.16e-04 | 347 | 48 | 5 | 17114649 | ||
| Pubmed | 1.22e-04 | 12 | 48 | 2 | 32414917 | ||
| Pubmed | Hippocampus development and generation of dentate gyrus granule cells is regulated by LEF1. | 1.22e-04 | 12 | 48 | 2 | 10631168 | |
| Pubmed | All Tcf HMG box transcription factors interact with Groucho-related co-repressors. | 1.22e-04 | 12 | 48 | 2 | 11266540 | |
| Pubmed | 1.28e-04 | 1429 | 48 | 9 | 35140242 | ||
| Pubmed | Tcf3 and Tcf4 are essential for long-term homeostasis of skin epithelia. | 1.44e-04 | 13 | 48 | 2 | 19718027 | |
| Pubmed | Investigation of genes important in neurodevelopment disorders in adult human brain. | 1.44e-04 | 13 | 48 | 2 | 26194112 | |
| Pubmed | 1.44e-04 | 13 | 48 | 2 | 11239002 | ||
| Pubmed | 1.68e-04 | 14 | 48 | 2 | 15226261 | ||
| Pubmed | 1.68e-04 | 14 | 48 | 2 | 33195246 | ||
| Pubmed | Wnt3a-/--like phenotype and limb deficiency in Lef1(-/-)Tcf1(-/-) mice. | 1.68e-04 | 14 | 48 | 2 | 10090727 | |
| Pubmed | Phases of canonical Wnt signaling during the development of mouse intestinal epithelium. | 1.94e-04 | 15 | 48 | 2 | 17681174 | |
| Pubmed | 2.10e-04 | 83 | 48 | 3 | 28794006 | ||
| Pubmed | Mutant Lef1 controls Gata6 in sebaceous gland development and cancer. | 2.21e-04 | 16 | 48 | 2 | 30886049 | |
| Pubmed | 2.21e-04 | 16 | 48 | 2 | 21920314 | ||
| Pubmed | 2.42e-04 | 407 | 48 | 5 | 12693553 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 2.44e-04 | 220 | 48 | 4 | 35785414 | |
| Pubmed | 2.62e-04 | 650 | 48 | 6 | 38777146 | ||
| Pubmed | Serological detection of cutaneous T-cell lymphoma-associated antigens. | 2.81e-04 | 18 | 48 | 2 | 11149944 | |
| Pubmed | 2.81e-04 | 18 | 48 | 2 | 22166339 | ||
| Pubmed | The contribution of de novo coding mutations to autism spectrum disorder. | 2.81e-04 | 18 | 48 | 2 | 25363768 | |
| Pubmed | 2.81e-04 | 18 | 48 | 2 | 27720610 | ||
| Pubmed | 3.12e-04 | 430 | 48 | 5 | 32581705 | ||
| Pubmed | Wnt/β-catenin signaling in the dental mesenchyme regulates incisor development by regulating Bmp4. | 3.14e-04 | 19 | 48 | 2 | 20883686 | |
| Pubmed | hnRNPH1 recruits PTBP2 and SRSF3 to modulate alternative splicing in germ cells. | 3.14e-04 | 19 | 48 | 2 | 35739118 | |
| Pubmed | Sequential roles of Hedgehog and Wnt signaling in osteoblast development. | 3.49e-04 | 20 | 48 | 2 | 15576404 | |
| Pubmed | Function of Wnt/β-catenin in counteracting Tcf3 repression through the Tcf3-β-catenin interaction. | 3.49e-04 | 20 | 48 | 2 | 22573616 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 3.60e-04 | 1294 | 48 | 8 | 30804502 | |
| Pubmed | A Highly Conserved Shh Enhancer Coordinates Hypothalamic and Craniofacial Development. | 3.85e-04 | 21 | 48 | 2 | 33869166 | |
| Pubmed | Tcf7l1 protects the anterior neural fold from adopting the neural crest fate. | 3.85e-04 | 21 | 48 | 2 | 27302397 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 4.12e-04 | 457 | 48 | 5 | 32344865 | |
| Pubmed | 4.23e-04 | 22 | 48 | 2 | 21979435 | ||
| Pubmed | 4.23e-04 | 22 | 48 | 2 | 21775418 | ||
| Pubmed | 4.63e-04 | 23 | 48 | 2 | 16637659 | ||
| Pubmed | 4.63e-04 | 23 | 48 | 2 | 9225980 | ||
| Pubmed | 4.79e-04 | 263 | 48 | 4 | 34702444 | ||
| Pubmed | 4.79e-04 | 263 | 48 | 4 | 20932939 | ||
| Pubmed | The Hippo Pathway Prevents YAP/TAZ-Driven Hypertranscription and Controls Neural Progenitor Number. | 5.05e-04 | 24 | 48 | 2 | 30523785 | |
| Pubmed | 5.14e-04 | 268 | 48 | 4 | 33640491 | ||
| Interaction | CTAGE1 interactions | 1.32e-06 | 10 | 46 | 3 | int:CTAGE1 | |
| Interaction | AJUBA interactions | 3.67e-06 | 103 | 46 | 5 | int:AJUBA | |
| Interaction | CTAGE4 interactions | 1.53e-05 | 3 | 46 | 2 | int:CTAGE4 | |
| Interaction | WWC2 interactions | 3.50e-05 | 28 | 46 | 3 | int:WWC2 | |
| Interaction | GSC interactions | 4.60e-05 | 87 | 46 | 4 | int:GSC | |
| Interaction | SYNE3 interactions | 6.12e-05 | 444 | 46 | 7 | int:SYNE3 | |
| Interaction | NUP43 interactions | 7.54e-05 | 625 | 46 | 8 | int:NUP43 | |
| Interaction | CTAGE8 interactions | 7.60e-05 | 6 | 46 | 2 | int:CTAGE8 | |
| Interaction | ACAD8 interactions | 8.19e-05 | 37 | 46 | 3 | int:ACAD8 | |
| Interaction | SNRNP40 interactions | 8.61e-05 | 637 | 46 | 8 | int:SNRNP40 | |
| Interaction | MIA2 interactions | 1.28e-04 | 113 | 46 | 4 | int:MIA2 | |
| Interaction | PLRG1 interactions | 1.29e-04 | 216 | 46 | 5 | int:PLRG1 | |
| Interaction | KLF3 interactions | 1.67e-04 | 228 | 46 | 5 | int:KLF3 | |
| Interaction | TSC1 interactions | 1.75e-04 | 366 | 46 | 6 | int:TSC1 | |
| Interaction | UFSP1 interactions | 1.91e-04 | 49 | 46 | 3 | int:UFSP1 | |
| Interaction | ZNF34 interactions | 1.91e-04 | 49 | 46 | 3 | int:ZNF34 | |
| Interaction | TLE3 interactions | 2.02e-04 | 376 | 46 | 6 | int:TLE3 | |
| Interaction | DLG3 interactions | 2.25e-04 | 131 | 46 | 4 | int:DLG3 | |
| Interaction | CRX interactions | 2.75e-04 | 254 | 46 | 5 | int:CRX | |
| Interaction | MOB3B interactions | 2.77e-04 | 11 | 46 | 2 | int:MOB3B | |
| Cytoband | 7q22 | 7.35e-04 | 38 | 48 | 2 | 7q22 | |
| Cytoband | 7q35 | 1.53e-03 | 55 | 48 | 2 | 7q35 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q35 | 2.20e-03 | 66 | 48 | 2 | chr7q35 | |
| Cytoband | 19p13.11 | 2.68e-03 | 73 | 48 | 2 | 19p13.11 | |
| Cytoband | 2q35 | 3.13e-03 | 79 | 48 | 2 | 2q35 | |
| GeneFamily | CTAGE family | 6.21e-09 | 15 | 28 | 4 | 907 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.70e-04 | 206 | 28 | 4 | 682 | |
| GeneFamily | Protein tyrosine phosphatases, non-receptor type | 3.48e-04 | 18 | 28 | 2 | 812 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 6.79e-04 | 25 | 28 | 2 | 775 | |
| GeneFamily | PDZ domain containing | 1.64e-03 | 152 | 28 | 3 | 1220 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 2.71e-03 | 50 | 28 | 2 | 1293 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.65e-06 | 189 | 47 | 5 | c392491aabe8a3e90974ab2ea123bbbe5200439d | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.65e-06 | 189 | 47 | 5 | 473b01c9162b12b90a617c600238436177a0d18d | |
| ToppCell | droplet-Kidney-nan-18m-Endothelial-kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-05 | 176 | 47 | 4 | 5386386619cf173939d3c117b20e6f27ab397993 | |
| ToppCell | droplet-Kidney-nan-18m-Endothelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-05 | 176 | 47 | 4 | 820edade963768e4bfd86b554da4cd7100567ac8 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-05 | 181 | 47 | 4 | 269b39ac65790061d54eab47a8eeb024403f0348 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-05 | 181 | 47 | 4 | cd4f744b6b64ba6c22ec07afd1d3058a2546909d | |
| ToppCell | facs-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-05 | 181 | 47 | 4 | c8395ae872aa80b3ae1ab7c53e57b3ca15aeb0e2 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-05 | 188 | 47 | 4 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-05 | 190 | 47 | 4 | 8cb950effc449ae59a915132ecc079be54d1acfe | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-05 | 190 | 47 | 4 | 17a73a658fb30a4322b31e38db7b240023738f29 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-05 | 190 | 47 | 4 | 5dfbd064ab1f8a0b18b5975c47f8e79697f3db15 | |
| ToppCell | ILEUM-non-inflamed-(8)_Activated_fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.77e-05 | 190 | 47 | 4 | 39fa110d19c97c7cac99f5fb91b26bc08e2f3b42 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-05 | 191 | 47 | 4 | b9ae5af426e7a1f2652a47700bb168371bd2dec6 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.07e-05 | 193 | 47 | 4 | 09de51f8ac509e03d480ed3dc9dfe7e7defc59cb | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.07e-05 | 193 | 47 | 4 | 03678162648bd5b1d65a5450b60c8863edbf95c7 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.07e-05 | 193 | 47 | 4 | 59b8186d0221fba06a16157e9d148399ed801f38 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.07e-05 | 193 | 47 | 4 | 2e72309607902dabe3218888b22a77fe941f3570 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.07e-05 | 193 | 47 | 4 | dc92680b4bb9fc26430c92e03adb839c8c3b3b98 | |
| ToppCell | facs-GAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.17e-05 | 194 | 47 | 4 | 9709dc95fb6982b6a0467b507845d5bc17252e3e | |
| ToppCell | facs-Kidney-nan-18m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.17e-05 | 194 | 47 | 4 | bbc625b4cc53bb7d6254fde287258e51f9171572 | |
| ToppCell | facs-GAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.17e-05 | 194 | 47 | 4 | 93b7a9065430740ec31fce4e8c14ffccb498591d | |
| ToppCell | facs-Kidney-nan-18m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.17e-05 | 194 | 47 | 4 | fcd5e9238d299c41f0bf9693b56cd8c900d2112b | |
| ToppCell | facs-MAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.17e-05 | 194 | 47 | 4 | f906b090f67df4cfe3498cdbb52cc0efa08e06cc | |
| ToppCell | facs-GAT-Fat-18m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.17e-05 | 194 | 47 | 4 | 0d2e65b44e3f143971c2fd24c4552f042b049cfa | |
| ToppCell | facs-Kidney-nan-18m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.17e-05 | 194 | 47 | 4 | 6afc21c5fec30ab8e373e3e46ab7866204c805b6 | |
| ToppCell | facs-MAT-Fat-18m-Mesenchymal|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.17e-05 | 194 | 47 | 4 | 944cdb0403d80a10a2eea2a3516a9343dbccc32c | |
| ToppCell | facs-MAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.17e-05 | 194 | 47 | 4 | 85081d255fcc1e9854c0073321dd9f0feaa48866 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.38e-05 | 196 | 47 | 4 | ee45e4de9d706ec87094e87f47d3e514539b8092 | |
| ToppCell | facs-SCAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.38e-05 | 196 | 47 | 4 | 65f2f51e17f1869f3468813127b96d3048d8ad41 | |
| ToppCell | facs-SCAT-Fat-18m-Mesenchymal|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.38e-05 | 196 | 47 | 4 | 2cd83176f2e8a9e6fa3c08cb33928a61e5fc43b6 | |
| ToppCell | facs-SCAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.38e-05 | 196 | 47 | 4 | e4ed897900a6472738bc6be2fb4817192727225d | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.38e-05 | 196 | 47 | 4 | fa4a85a3cd52df0da5dfedc0e584e9df8c61ce89 | |
| ToppCell | facs-Heart-RA-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.49e-05 | 197 | 47 | 4 | 940cf1e54d7c820e04946258a8b784f35c6a144c | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.60e-05 | 198 | 47 | 4 | 8a55589b9244283e4b0b423a4a6d6202e8e0fec9 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Mesothelial-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 5.71e-05 | 199 | 47 | 4 | 60a653100aff31f7f96796ff2ec634798bfb4b0d | |
| ToppCell | Bronchial-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.71e-05 | 199 | 47 | 4 | 45c3b853900d8c3d5965117d904e3714100138bc | |
| ToppCell | pdx-Tumor_cells-T9|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.70e-04 | 144 | 47 | 3 | 0b94d978262a826c9254145aa98c6c30240243f9 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Hematologic-MPP_Fraction_B|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.82e-04 | 155 | 47 | 3 | 9b26ade19488511c72b64335011d2dcd81e8f167 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.82e-04 | 155 | 47 | 3 | cd2f3ad4f131588325a667b6724e530d821fbe30 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.82e-04 | 155 | 47 | 3 | 4246709e27703b94529369abbed5763e4002e79d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.82e-04 | 155 | 47 | 3 | 59035d792c26d870a8b097939e97fa47859ba68c | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.04e-04 | 157 | 47 | 3 | d8e283414a770f05d71f0455d0822e9a9660b115 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.04e-04 | 157 | 47 | 3 | 165e98bf944572cafbc06ef43c9eab7bd6bea1c2 | |
| ToppCell | CV-Healthy-3|CV / Virus stimulation, Condition and Cluster | 6.50e-04 | 161 | 47 | 3 | fd4a79385ea967b9900dc76a3add813b894a3a28 | |
| ToppCell | Basal_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 6.85e-04 | 164 | 47 | 3 | 85487a303194f5244956ec1ca2d1758d38117f41 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D231|Adult / Lineage, Cell type, age group and donor | 6.85e-04 | 164 | 47 | 3 | 2ba57dce5f69a88f0d1e450b9780425e2d9ca7d4 | |
| ToppCell | facs-Spleen-nan-18m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.10e-04 | 166 | 47 | 3 | 8d535fab019356894b4dad3fbdbc4d2ad3e16082 | |
| ToppCell | facs-Spleen-nan-18m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.10e-04 | 166 | 47 | 3 | f56b1c0d6cb5353a16a2598bda905287f16d2c39 | |
| ToppCell | facs-Spleen-nan-18m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.10e-04 | 166 | 47 | 3 | a5074c96c6561273029aceb93402a7e038140f50 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D231|Adult / Lineage, Cell type, age group and donor | 7.22e-04 | 167 | 47 | 3 | 5af9127bae05768a5164d5708a4ad37edca99324 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.35e-04 | 168 | 47 | 3 | d823979335ac6b5d1f062ebb741c759d2f919dbf | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-non-classical_monocyte|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.35e-04 | 168 | 47 | 3 | f377ff4c066a9857ad14d245e56325ad220e22e1 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.48e-04 | 169 | 47 | 3 | c96e0f3241d13926dbee9f91c0c8c5bfa7479a0d | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.48e-04 | 169 | 47 | 3 | ba023ee7bb165c2bfbefc2d969ff32ca1eeed33b | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.48e-04 | 169 | 47 | 3 | 335619507857383c3b0b507cdf05d786ed59e585 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.61e-04 | 170 | 47 | 3 | d7c9a604311974ff87ece43a0f8725a234d262f7 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.87e-04 | 172 | 47 | 3 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6-Excitatory_Neuron.Slc17a7.Bcl6-Fos_(Layer_5a,_IEG+)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 8.12e-04 | 40 | 47 | 2 | b4c04100180790e1a53a15e8311e40015306c088 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.13e-04 | 174 | 47 | 3 | 4cdf2eedc28d88d18241ee390092426fdf849e79 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.13e-04 | 174 | 47 | 3 | 268be5e7d2a18b866770b7cdb966c3958c7e6534 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.13e-04 | 174 | 47 | 3 | 68a6ed81e7e1f95b61f7ee20403980fa3a8db4d0 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.13e-04 | 174 | 47 | 3 | 1d157f7a919c8246e83d8060d2a0017c6c781ef3 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.27e-04 | 175 | 47 | 3 | d8e385320f554d974538b7cdc4f8e4767f1455f2 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.27e-04 | 175 | 47 | 3 | cf15465855602ba135752c18755e3e058dbd42ec | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.41e-04 | 176 | 47 | 3 | c0a084f7a8645262d61971f094689e02bf15b113 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.41e-04 | 176 | 47 | 3 | f25251abd4ef9fb077a978f9f9f658af58e4e0d2 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.41e-04 | 176 | 47 | 3 | cccf9201f6e2da7524b911a5961d3b227edab222 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.41e-04 | 176 | 47 | 3 | dc5a22f9d1347f157bdd93e6e5769b983deccf1a | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Endothelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.41e-04 | 176 | 47 | 3 | c4d9166e5bbb7ca544107db14e4374289f5de6bd | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.41e-04 | 176 | 47 | 3 | fee4e0f32aaf77294040c7af6c1f503571750d43 | |
| ToppCell | AT1_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 8.41e-04 | 176 | 47 | 3 | 458720776b0151cd55acc352d509599cb62f0ca8 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Endothelial-kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.41e-04 | 176 | 47 | 3 | d58ef51002ea50b3037636038214bbb7454cb503 | |
| ToppCell | PND07-28-samps-Endothelial-Postnatal_endothelial-endothelial_cells_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 8.55e-04 | 177 | 47 | 3 | 6da88c358b3a2e47fa3472217a38b6b00ad7b280 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.69e-04 | 178 | 47 | 3 | 5289ac61637224ae70ffbc2d164d73116f10af40 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.69e-04 | 178 | 47 | 3 | 8f31b3fac51591f7f2bcb898c07708b3e9f93a16 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.69e-04 | 178 | 47 | 3 | 8151e5d73407fd9cba382b69a2bc707c81790c7f | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.69e-04 | 178 | 47 | 3 | 30ca37f70d267cc9b40ca3e211f16d30360c3e6b | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.83e-04 | 179 | 47 | 3 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | droplet-Kidney-nan-21m-Endothelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.83e-04 | 179 | 47 | 3 | ba38177ffcf3a20f02afeeaaa91bc8eab8d1ac05 | |
| ToppCell | droplet-Kidney-nan-21m-Endothelial-kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.83e-04 | 179 | 47 | 3 | d121351b4c3b91108e6c5753d18a44d676f38d4c | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.97e-04 | 180 | 47 | 3 | be10fe5bf7c3a671c42704ce7dd8226ab6896794 | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.97e-04 | 180 | 47 | 3 | f9f8245cbcdea18c15e2976c85b72c6807309787 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.97e-04 | 180 | 47 | 3 | a682a5d55c612709c9ee9fa4289d6f8bef7fe1af | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.97e-04 | 180 | 47 | 3 | 3b747a517ce75ef2ff09011c037dad7b01ed3e03 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.12e-04 | 181 | 47 | 3 | 41969fe4d94ee77b12ecde32170aaf0b13e49644 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.12e-04 | 181 | 47 | 3 | 3f50e61dc2a52d71a5801584617607e6246adcf2 | |
| ToppCell | P28-Mesenchymal|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.26e-04 | 182 | 47 | 3 | 69f9d44694fe4f55a971ae0ac5dc3e7448ee78f3 | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.26e-04 | 182 | 47 | 3 | f4b74c2756989812abe4e7055ec8918f69d56025 | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 9.41e-04 | 183 | 47 | 3 | de08f9ea02b7244d5a8788064631d10f06565337 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.41e-04 | 183 | 47 | 3 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.41e-04 | 183 | 47 | 3 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.41e-04 | 183 | 47 | 3 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.41e-04 | 183 | 47 | 3 | f55081068213cc1cdb2acad58ff10f6b48b44c72 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 9.56e-04 | 184 | 47 | 3 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 9.56e-04 | 184 | 47 | 3 | 2c2125b8030af83f7a6d59a7102d4de8e0ac1988 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.56e-04 | 184 | 47 | 3 | 7294b379ce4cb8fa75e432559082f93cd106aaf5 | |
| ToppCell | Control-CD8+_T_activated|Control / Disease group and Cell class | 9.56e-04 | 184 | 47 | 3 | b86cc48b744b3206880ec1373fe6068e14bf9680 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.56e-04 | 184 | 47 | 3 | 1c857126c0ea0671f0d60b048efca288d348d653 | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.71e-04 | 185 | 47 | 3 | 9954fc85b183c1cc45c3c24e3dadc7984ee6f649 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.71e-04 | 185 | 47 | 3 | 3cd0686a14e734a0f243070ab939adcb4c454478 | |
| Drug | Nalbuphine hydrochloride [23277-43-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 2.46e-06 | 198 | 45 | 6 | 7177_DN | |
| Drug | Aminophylline [317-34-0]; Up 200; 9.6uM; PC3; HT_HG-U133A | 2.54e-06 | 199 | 45 | 6 | 6295_UP | |
| Drug | 1-anilino-4-methyl-2-methylthio-4-phenylimidazolin-5-one | 7.95e-06 | 373 | 45 | 7 | ctd:C540355 | |
| Drug | pyrachlostrobin | 2.47e-05 | 811 | 45 | 9 | ctd:C513428 | |
| Drug | Econazole nitrate [24169-02-6]; Down 200; 9uM; MCF7; HT_HG-U133A | 3.76e-05 | 192 | 45 | 5 | 7427_DN | |
| Drug | Fluticasone propionate [80474-14-2]; Up 200; 8uM; MCF7; HT_HG-U133A | 3.76e-05 | 192 | 45 | 5 | 4129_UP | |
| Drug | Cisapride [81098-60-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 4.05e-05 | 195 | 45 | 5 | 5305_UP | |
| Drug | Luteolin [491-70-3]; Down 200; 14uM; MCF7; HT_HG-U133A | 4.05e-05 | 195 | 45 | 5 | 5004_DN | |
| Drug | Sulfaguanidine [57-67-0]; Up 200; 18.6uM; HL60; HG-U133A | 4.15e-05 | 196 | 45 | 5 | 1995_UP | |
| Drug | Morantel tartrate [26155-31-7]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 4.15e-05 | 196 | 45 | 5 | 7010_UP | |
| Drug | Ajmaline [4360-12-7]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 4.25e-05 | 197 | 45 | 5 | 2899_DN | |
| Drug | troglitazone; Up 200; 10uM; MCF7; HT_HG-U133A | 4.25e-05 | 197 | 45 | 5 | 6991_UP | |
| Drug | Lobelanidine hydrochloride [6112-86-3]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 4.36e-05 | 198 | 45 | 5 | 5500_UP | |
| Drug | Gabazine [105538-73-6]; Down 200; 10.8uM; HL60; HT_HG-U133A | 4.36e-05 | 198 | 45 | 5 | 1316_DN | |
| Drug | Ambroxol hydrochloride [23828-92-4]; Up 200; 9.6uM; HL60; HG-U133A | 4.46e-05 | 199 | 45 | 5 | 1623_UP | |
| Drug | Molsidomine [25717-80-0]; Down 200; 16.6uM; MCF7; HT_HG-U133A | 4.46e-05 | 199 | 45 | 5 | 2862_DN | |
| Drug | Trolox [53188-07-1]; Up 200; 16uM; HL60; HG-U133A | 4.46e-05 | 199 | 45 | 5 | 1734_UP | |
| Drug | Glipizide [29094-61-9]; Up 200; 9uM; HL60; HG-U133A | 4.57e-05 | 200 | 45 | 5 | 2008_UP | |
| Drug | AC1L9JS4 | 1.08e-04 | 125 | 45 | 4 | CID000446532 | |
| Drug | GSK1210151A | 1.49e-04 | 52 | 45 | 3 | ctd:C568713 | |
| Drug | pyrvinium pamoate; Up 200; 1.25uM; MCF7; HT_HG-U133A_EA | 4.10e-04 | 177 | 45 | 4 | 870_UP | |
| Drug | Hycanthone [3105-97-3]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 4.28e-04 | 179 | 45 | 4 | 5691_UP | |
| Drug | genistein; Down 200; 10uM; HL60; HT_HG-U133A | 5.15e-04 | 188 | 45 | 4 | 1176_DN | |
| Drug | geldanamycin; Down 200; 1uM; HL60; HT_HG-U133A | 5.15e-04 | 188 | 45 | 4 | 6187_DN | |
| Drug | Thioperamide maleate [106243-16-7]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 5.46e-04 | 191 | 45 | 4 | 3392_UP | |
| Drug | Homatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; PC3; HT_HG-U133A | 5.57e-04 | 192 | 45 | 4 | 5058_DN | |
| Drug | STOCK1N-28457; Down 200; 20uM; MCF7; HT_HG-U133A | 5.68e-04 | 193 | 45 | 4 | 6869_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; HL60; HT_HG-U133A | 5.68e-04 | 193 | 45 | 4 | 1183_UP | |
| Drug | Piperine [94-62-2]; Down 200; 14uM; MCF7; HT_HG-U133A | 5.68e-04 | 193 | 45 | 4 | 3263_DN | |
| Drug | Cefalonium [5575-21-3]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 5.68e-04 | 193 | 45 | 4 | 7341_UP | |
| Drug | Rolipram [61413-54-5]; Up 200; 14.6uM; PC3; HT_HG-U133A | 5.68e-04 | 193 | 45 | 4 | 6730_UP | |
| Drug | Dirithromycin [62013-04-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 5.79e-04 | 194 | 45 | 4 | 2863_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A_EA | 5.79e-04 | 194 | 45 | 4 | 1060_UP | |
| Drug | Harmol hydrochloride monohydrate [40580-83-4]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 5.79e-04 | 194 | 45 | 4 | 2900_DN | |
| Drug | alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A_EA | 5.79e-04 | 194 | 45 | 4 | 990_DN | |
| Drug | Cefoperazone dihydrate; Down 200; 5.8uM; MCF7; HT_HG-U133A | 5.91e-04 | 195 | 45 | 4 | 5424_DN | |
| Drug | Esculin Hydrate [531-75-9]; Down 200; 11.8uM; PC3; HT_HG-U133A | 5.91e-04 | 195 | 45 | 4 | 6310_DN | |
| Drug | Cyclobenzaprine hydrochloride [6202-23-9]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 5.91e-04 | 195 | 45 | 4 | 3268_UP | |
| Drug | Berberine chloride [633-65-8]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 5.91e-04 | 195 | 45 | 4 | 2770_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; PC3; HT_HG-U133A | 5.91e-04 | 195 | 45 | 4 | 4433_DN | |
| Drug | Iproniazide phosphate [305-33-9]; Down 200; 14.4uM; PC3; HT_HG-U133A | 5.91e-04 | 195 | 45 | 4 | 2125_DN | |
| Drug | Naringenine [480-41-1]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 5.91e-04 | 195 | 45 | 4 | 3278_UP | |
| Drug | Piperidolate hydrochloride [129-77-1]; Down 200; 11.2uM; HL60; HT_HG-U133A | 5.91e-04 | 195 | 45 | 4 | 6129_DN | |
| Drug | Kawain [500-64-1]; Up 200; 17.4uM; PC3; HT_HG-U133A | 6.02e-04 | 196 | 45 | 4 | 7369_UP | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 6.02e-04 | 196 | 45 | 4 | 987_DN | |
| Drug | Gemfibrozil [25812-30-0]; Down 200; 16uM; PC3; HT_HG-U133A | 6.02e-04 | 196 | 45 | 4 | 5069_DN | |
| Drug | Paclitaxel [33069-62-4]; Up 200; 4.6uM; MCF7; HT_HG-U133A | 6.02e-04 | 196 | 45 | 4 | 5320_UP | |
| Drug | Methoxy-8-psoralen [298-81-7]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 6.02e-04 | 196 | 45 | 4 | 3302_DN | |
| Drug | Phthalylsulfathiazole [85-73-4]; Up 200; 10uM; MCF7; HT_HG-U133A | 6.02e-04 | 196 | 45 | 4 | 3371_UP | |
| Drug | 6-Furfurylaminopurine [525-79-1]; Up 200; 18.6uM; HL60; HT_HG-U133A | 6.02e-04 | 196 | 45 | 4 | 2511_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 500uM; MCF7; HT_HG-U133A_EA | 6.02e-04 | 196 | 45 | 4 | 1078_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 50uM; MCF7; HT_HG-U133A_EA | 6.02e-04 | 196 | 45 | 4 | 1002_DN | |
| Drug | Condelphine [7633-69-4]; Down 200; 8.8uM; PC3; HT_HG-U133A | 6.02e-04 | 196 | 45 | 4 | 6357_DN | |
| Drug | Ethisterone [434-03-7]; Down 200; 12.8uM; PC3; HT_HG-U133A | 6.02e-04 | 196 | 45 | 4 | 3783_DN | |
| Drug | Zardaverine [101975-10-4]; Down 200; 15uM; MCF7; HT_HG-U133A | 6.02e-04 | 196 | 45 | 4 | 4793_DN | |
| Drug | LY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A | 6.02e-04 | 196 | 45 | 4 | 6976_DN | |
| Drug | Kanamycin A sulfate [25389-94-0]; Down 200; 6.8uM; MCF7; HT_HG-U133A | 6.02e-04 | 196 | 45 | 4 | 5686_DN | |
| Drug | Sulfathiazole [72-14-0]; Down 200; 15.6uM; MCF7; HT_HG-U133A | 6.02e-04 | 196 | 45 | 4 | 4769_DN | |
| Drug | Moxisylyte hydrochoride [964-52-3]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 6.02e-04 | 196 | 45 | 4 | 7015_UP | |
| Drug | Mifepristone [84371-65-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 6.02e-04 | 196 | 45 | 4 | 7183_DN | |
| Drug | Clozapine [5786-21-0]; Down 200; 12.2uM; HL60; HT_HG-U133A | 6.02e-04 | 196 | 45 | 4 | 1289_DN | |
| Drug | Isopyrin hydrochloride [18342-39-7]; Down 200; 14.2uM; HL60; HT_HG-U133A | 6.02e-04 | 196 | 45 | 4 | 2534_DN | |
| Drug | Midecamycin [35457-80-8]; Up 200; 5uM; MCF7; HT_HG-U133A | 6.02e-04 | 196 | 45 | 4 | 5345_UP | |
| Drug | Metrizamide [31112-62-6]; Down 200; 5uM; MCF7; HT_HG-U133A | 6.02e-04 | 196 | 45 | 4 | 3255_DN | |
| Drug | Tranexamic acid [1197-18-8]; Down 200; 25.4uM; MCF7; HT_HG-U133A | 6.02e-04 | 196 | 45 | 4 | 6238_DN | |
| Drug | Dienestrol [84-17-3]; Down 200; 15uM; MCF7; HT_HG-U133A | 6.02e-04 | 196 | 45 | 4 | 3448_DN | |
| Drug | Norethindrone [68-22-4]; Down 200; 13.4uM; HL60; HT_HG-U133A | 6.02e-04 | 196 | 45 | 4 | 2383_DN | |
| Drug | Amiodarone hydrochloride [19774-82-4]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 6.14e-04 | 197 | 45 | 4 | 5618_UP | |
| Drug | Aconitine [302-27-2]; Down 200; 6.2uM; PC3; HT_HG-U133A | 6.14e-04 | 197 | 45 | 4 | 7149_DN | |
| Drug | Antipyrine, 4-hydroxy [1672-63-5]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 6.14e-04 | 197 | 45 | 4 | 1497_DN | |
| Drug | Enoxacin [74011-58-8]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 6.14e-04 | 197 | 45 | 4 | 5616_DN | |
| Drug | Crotamiton [483-63-6]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 6.14e-04 | 197 | 45 | 4 | 3388_UP | |
| Drug | Meticrane [1084-65-7]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 6.14e-04 | 197 | 45 | 4 | 1671_DN | |
| Drug | Streptomycin sulfate [3810-74-0]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 6.14e-04 | 197 | 45 | 4 | 7194_DN | |
| Drug | Troleandomycin [2751-09-9]; Up 200; 5uM; PC3; HG-U133A | 6.14e-04 | 197 | 45 | 4 | 1885_UP | |
| Drug | Fenofibrate [49562-28-9]; Up 200; 11uM; MCF7; HT_HG-U133A | 6.14e-04 | 197 | 45 | 4 | 7474_UP | |
| Drug | Ifosfamide [3778-73-2]; Down 200; 15.4uM; PC3; HT_HG-U133A | 6.14e-04 | 197 | 45 | 4 | 5805_DN | |
| Drug | U-62066 [87151-85-7]; Down 200; 1uM; PC3; HT_HG-U133A | 6.14e-04 | 197 | 45 | 4 | 4553_DN | |
| Drug | Fenbufen [36330-85-5]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 6.14e-04 | 197 | 45 | 4 | 2308_UP | |
| Drug | Allantoin [97-59-6]; Up 200; 25.2uM; HL60; HT_HG-U133A | 6.14e-04 | 197 | 45 | 4 | 1842_UP | |
| Drug | Cinoxacin [28657-80-9]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 6.14e-04 | 197 | 45 | 4 | 6257_DN | |
| Drug | Sulfacetamide sodic hydrate [6209-17-2]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 6.14e-04 | 197 | 45 | 4 | 1695_UP | |
| Drug | Dimethadione [695-53-4]; Down 200; 31uM; MCF7; HT_HG-U133A | 6.14e-04 | 197 | 45 | 4 | 5668_DN | |
| Drug | Ivermectin [70288-86-7]; Down 200; 4.6uM; MCF7; HT_HG-U133A | 6.14e-04 | 197 | 45 | 4 | 7206_DN | |
| Drug | Cefamandole sodium salt [30034-03-8]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 6.14e-04 | 197 | 45 | 4 | 3436_DN | |
| Drug | Niridazole [61-57-4]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 6.14e-04 | 197 | 45 | 4 | 5682_DN | |
| Drug | Terbutaline hemisulfate [23031-32-5]; Down 200; 7.2uM; MCF7; HT_HG-U133A | 6.14e-04 | 197 | 45 | 4 | 6240_DN | |
| Drug | STOCK1N-35696; Down 200; 15uM; MCF7; HT_HG-U133A | 6.14e-04 | 197 | 45 | 4 | 6577_DN | |
| Drug | LY 294002; Up 200; 0.1uM; HL60; HT_HG-U133A | 6.14e-04 | 197 | 45 | 4 | 2676_UP | |
| Drug | AC1L9NAZ | 6.25e-04 | 198 | 45 | 4 | CID000449606 | |
| Drug | Hydrocotarnine hydrobromide [5985-00-2]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 6.25e-04 | 198 | 45 | 4 | 6827_DN | |
| Drug | Trapidil [15421-84-8]; Up 200; 19.4uM; HL60; HT_HG-U133A | 6.25e-04 | 198 | 45 | 4 | 3136_UP | |
| Drug | Meropenem [96036-03-2]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 6.25e-04 | 198 | 45 | 4 | 7180_DN | |
| Drug | Pyrilamine maleate [59-33-6]; Down 200; 10uM; PC3; HT_HG-U133A | 6.25e-04 | 198 | 45 | 4 | 5869_DN | |
| Drug | Fluorocurarine chloride [22273-09-2]; Up 200; 11.6uM; HL60; HT_HG-U133A | 6.25e-04 | 198 | 45 | 4 | 2521_UP | |
| Drug | Ajmalicine hydrochloride [4373-34-6]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 6.25e-04 | 198 | 45 | 4 | 2898_DN | |
| Drug | Theobromine [83-67-0]; Down 200; 22.2uM; MCF7; HT_HG-U133A | 6.25e-04 | 198 | 45 | 4 | 4958_DN | |
| Drug | Hymecromone [90-33-5]; Down 200; 22.8uM; MCF7; HT_HG-U133A | 6.25e-04 | 198 | 45 | 4 | 5684_DN | |
| Drug | Methoxy-6-harmalan [3589-73-9]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 6.25e-04 | 198 | 45 | 4 | 2893_DN | |
| Drug | Milrinone [78415-72-2]; Down 200; 19uM; MCF7; HT_HG-U133A | 6.25e-04 | 198 | 45 | 4 | 7210_DN | |
| Disease | thoracic aortic aneurysm | 1.14e-05 | 30 | 43 | 3 | EFO_0004282 | |
| Disease | Mental Retardation, X-Linked 1 | 1.39e-05 | 32 | 43 | 3 | C2931498 | |
| Disease | Phyllodes Tumor | 2.07e-05 | 5 | 43 | 2 | C0010701 | |
| Disease | Malignant Cystosarcoma Phyllodes | 2.07e-05 | 5 | 43 | 2 | C0600066 | |
| Disease | benign neoplasm (implicated_via_orthology) | 5.78e-05 | 8 | 43 | 2 | DOID:0060072 (implicated_via_orthology) | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 6.42e-05 | 53 | 43 | 3 | C4707243 | |
| Disease | colorectal cancer | 2.30e-04 | 604 | 43 | 6 | MONDO_0005575 | |
| Disease | bone density | 2.45e-04 | 388 | 43 | 5 | EFO_0003923 | |
| Disease | Abnormality of refraction | 4.09e-04 | 673 | 43 | 6 | HP_0000539 | |
| Disease | Sezary Syndrome | 7.11e-04 | 27 | 43 | 2 | C0036920 | |
| Disease | Malignant neoplasm of breast | 8.50e-04 | 1074 | 43 | 7 | C0006142 | |
| Disease | stomach cancer (is_marker_for) | 1.17e-03 | 142 | 43 | 3 | DOID:10534 (is_marker_for) | |
| Disease | refractive error | 1.29e-03 | 326 | 43 | 4 | MONDO_0004892 | |
| Disease | colorectal cancer, colorectal adenoma | 1.42e-03 | 152 | 43 | 3 | EFO_0005406, MONDO_0005575 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VYLQKYPPPLIPPRG | 461 | P35626 | |
| GYRLPDYPRPGRPVP | 1056 | P78357 | |
| YPPRGLPPYLHPRPG | 756 | Q8IX94 | |
| YPPRGLPPYLHPRPG | 756 | P0CG41 | |
| YPPRGLPPYLHPRPG | 756 | A4FU28 | |
| PPGPPEIYYTSRPPA | 1416 | O94910 | |
| PYRPPVPRAPDPAYI | 711 | Q14687 | |
| PPPAAPPRVYQPPTY | 216 | Q9UKU9 | |
| KGSLPEFYYRPPRPP | 81 | P46527 | |
| SYLREPPYSRLPPPP | 731 | Q5TC82 | |
| PRPHPVPDYELKYPP | 141 | Q9H607 | |
| VRPPMPPRYPAPYGE | 216 | Q86TB9 | |
| APPPYEDRNPLYPGP | 6 | Q969X1 | |
| PYVLHGRPYRPPSPP | 146 | O75593 | |
| YGGPDRRCPPPPYPK | 506 | Q9NRM7 | |
| YGPPRALEPPYLPVR | 321 | Q08397 | |
| IYPPPELPRDYRPVH | 361 | Q9BRR8 | |
| RPRPRAYYLEPLPLP | 1731 | Q93074 | |
| PPRPDPRAPPARASY | 61 | P13985 | |
| PSPYPYPAERRPVVG | 521 | Q16825 | |
| PVPRPPVEYLYPSRE | 426 | P35555 | |
| PPVLPPEYIPPSFRR | 296 | Q15811 | |
| ELYPPPPPRPSYPER | 51 | P09017 | |
| YPAPPQVPPTRYSPI | 356 | Q92796 | |
| YPYPFRPLPPIPFPR | 46 | Q8NFU4 | |
| RPLTYPQYSPPQPRP | 66 | P15407 | |
| PERNYTLPPPPYPHL | 86 | Q9UKN5 | |
| VYPPRGFPPYLPPRP | 1361 | Q96PC5 | |
| RPVVFPYAAPPPQEP | 66 | Q96PX1 | |
| PRLRYSPYSIPVPVP | 636 | O15119 | |
| PGVEPYPYPIPTVPE | 286 | Q92733 | |
| YPYPIPTVPEELPPG | 291 | Q92733 | |
| PPPYSRLSPRDEYKP | 276 | O43541 | |
| NYLFRPPPPYPRPRP | 561 | Q15678 | |
| RRPYLPGQLPPPPLY | 26 | Q99935 | |
| PYYVGPIRILKPPFP | 111 | Q99935 | |
| PLLPPRFYPRYVLPL | 101 | Q96K37 | |
| RAYVYPVNPPPPSPE | 201 | Q8N4L4 | |
| LYIPPPPAEPYIPRD | 351 | Q8WXI2 | |
| YPTPSPPHPLYPGRR | 316 | Q5JTD0 | |
| RRPDRQAYEPPPPPA | 116 | Q15654 | |
| YPREPPRLEPQPYRE | 31 | Q6ZU65 | |
| IPRPPHPSELSPYYP | 221 | Q9HCS4 | |
| APPAPPAPRFDIYDP | 216 | Q9H7N4 | |
| PPICYPRKTYAPPAR | 186 | Q9P227 | |
| YSPPIQRRYSPSPPP | 596 | Q8IYB3 | |
| LYLPRPPADPARYPR | 871 | Q9BXP2 | |
| PRPPHPPDISPYYPL | 231 | Q9NQB0 | |
| PGPPDPAYRRRPVPI | 291 | Q66K66 | |
| EPRFPTAPPTYPPYP | 2186 | O14686 |